Setting the record straight on accelerated approval
PhRMA
MAY 22, 2023
Food and Drug Administration’s (FDA) accelerated approval program has served as a critical lifeline for patients with serious and life-threatening conditions. From its inception three decades ago, the pathway’s purpose has always been to get medicines to patients most in need, especially those who lack any viable treatment options.
Let's personalize your content